神经重症监护中的无监督聚类:一项系统评价
该系统评价检索Medline、Scopus、Web of Science截至2024年3月13日的文献,纳入18项在神经重症监护中应用无监督聚类的研究,其中12项聚焦创伤性脑损伤(TBI)。研究使用人口学、临床和监测数据(颅内压最常纳入,8/18项),采用传统方法(如k-means)和能保留时间维度的先进方法。12项研究中有9项通过无监督聚类识别出与临床结局相关的新表型。作者认为该方法可用于神经重症患者(尤其TBI)表型分型,并可能有助于预后判断,但需验证研究。
要点
- 18项神经重症监护无监督聚类研究中12项聚焦TBI,颅内压是最常纳入的监测变量(8/18项)。
- 12项研究中有9项通过无监督聚类识别出与临床结局相关的新表型。
- 聚类方法包括传统方法(如k-means)和能保留时间维度的先进方法。
- 作者认为无监督聚类可用于神经重症患者表型分型,尤其TBI患者,并可能用于预后判断。
- 作者指出该领域仍需验证研究,但该方法可能有助于改善结局预测模型、诊断和对病理生理的理解。
适用人群与场景
- 急性脑损伤患者,包括创伤性脑损伤(TBI)、蛛网膜下腔出血、脑出血、急性缺血性卒中及缺氧缺血性脑损伤,见于神经重症监护单元。
研究设计与关键结果
- 系统评价纳入18项在神经重症监护中应用无监督聚类的研究,检索数据库为Medline、Scopus、Web of Science,检索截至2024年3月13日。
- 研究主要聚焦TBI患者(12/18项)。
- 使用的数据包括人口学、临床和监测数据,其中颅内压最常被纳入(8/18项)。
- 聚类方法涵盖传统方法(如k-means)和能保留时间维度的先进方法。
- 12项研究中有9项通过无监督聚类识别出与临床结局相关的新表型。
证据类型、等级与局限
- 证据类型:系统评价,遵循PRISMA指南,注册号PROSPERO: CRD4202347097676。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为无监督聚类可用于神经重症患者表型分型,尤其TBI患者,涉及不同疾病阶段,并识别可能用于预后判断的聚类。
- 作者指出该领域仍需验证研究,但该方法可能有助于改善结局预测模型、诊断和对病理生理的理解。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Managing patients with acute brain injury in the neurocritical care (NCC) unit has become increasingly complex because of technological advances and increasing information derived from multiple data sources. Diverse data streams necessitate innovative approaches for clinicians to understand interactions between recorded variables. Unsupervised clustering integrates different data streams and could be supportive. Here, we provide a systematic review on the use of unsupervised clustering using NCC data. The primary objective was to provide an overview of clustering applications in NCC studies. As a secondary objective, we discuss considerations for future NCC studies. Databases (Medline, Scopus, Web of Science) were searched for unsupervised clustering in acute brain injury studies including traumatic brain injury (TBI), subarachnoid hemorrhage, intracerebral hemorrhage, acute ischemic stroke, and hypoxic-ischemic brain injury published until March 13th 2024. We performed the systematic review in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. We identified 18 studies that used unsupervised clustering in NCC. Predominantly, studies focused on patients with TBI (12 of 18 studies). Multiple research questions used a variety of resource data, including demographics, clinical- and monitoring data, of which intracranial pressure was most often included (8 of 18 studies). Studies also covered various clustering methods, both traditional methods (e.g., k-means) and advanced methods, which are able to retain the temporal aspect. Finally, unsupervised clustering identified novel phenotypes for clinical outcomes in 9 of 12 studies. Unsupervised clustering can be used to phenotype NCC patients, especially patients with TBI, in diverse disease stages and identify clusters that may be used for prognostication. Despite the need for validation studies, this methodology could help to improve outcome prediction models, diagnostics, and understanding of pathophysiology.Registration number: PROSPERO: CRD4202347097676.
参考来源
- Tas J, Rass V, Ianosi BA, et al. Unsupervised Clustering in Neurocritical Care: A Systematic Review. Neurocrit Care. 2024. PMID: 39562386. doi:10.1007/s12028-024-02140-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。